Karl E. Surma

Part of "Schilling" Wirtschafts-beratungs GmbH, Schilling Asset Management GmbH provides investment advice. The company is based in Vienna, Austria. The CEO of the Austrian company is Josef Schroll.

Zytoprotec GmbH develops and manufactures drugs for peritoneal dialysis. It specializes in the research and development of its pipeline, which encompasses PD-protec, a patented-protected solution and ICO-protec, a cytoprotective PD solution to address the market for non-glucose based PD solutions. The firm focus areas encompass portfolio management, therapeutic approach, patent management and research services. The company was founded by Karl Altenhuber, Christoph Aufricht and Christian Hoenig in 2007 and is headquartered in Vienna, Austria.